VIP (Vasoactive Intestinal Peptide) 5mg — 5mg penVIP (Vasoactive Intestinal Peptide) 5mg
Quality
Pharmacy grade
Form
Pen with case
Level
any
Consultation required · prescriber

VIP (Vasoactive Intestinal Peptide) 5mg

VIP 5mg is a naturally occurring neuropeptide, offered in a branded pre-filled pen with case only following online consultation and clinician approval.

£29/ 5mg pen
Available after consultation
VIP (Vasoactive Intestinal Peptide) 5mg
£29
Start consultation

Answer a short online consultation. A clinician reviews it, and you only pay if treatment is approved. Dispensed by our licensed facility.

Vasoactive Intestinal Peptide (VIP) is a signalling molecule naturally present in the body, including the nervous system and digestive tract. It is involved in several normal physiological processes, but these biological roles do not establish benefits from taking additional VIP.
Strength
5mg
Form
Pen with case
Supplied by
Licensed facility

What it is

VIP is a neuropeptide made up of 28 amino acids. It acts as a messenger between cells and has roles in blood vessel tone, digestive activity and immune signalling.

Welcuren’s VIP 5mg presentation is a branded pre-filled pen supplied with a case. The presentation and packaging do not demonstrate clinical effectiveness or regulatory approval.

Why people ask about it

Interest in VIP often comes from its biological roles and its appearance in discussions about wellness and longevity. Online descriptions can blur the distinction between what VIP does naturally in the body and what an externally supplied product has been shown to do.

Our clinicians help put these claims into context. There is no established evidence that this VIP pen improves general wellbeing or extends lifespan.

What the science says

Much of the evidence relevant to wellness claims comes from laboratory and animal work. Human research includes studies of synthetic VIP, also known as aviptadil, in particular clinical settings; findings are not directly transferable to this product, its presentation or routine wellness use.

Evidence remains insufficient to establish a favourable benefit–risk balance for VIP as a longevity intervention. Larger, well-controlled studies and longer follow-up would be needed to clarify relevant outcomes and safety.

How Welcuren works

Complete a short online consultation about your health and goals.

A clinician reviews your answers, may ask follow-up questions, and decides whether this treatment is appropriate for you.

You only pay once treatment is approved. Our licensed facility then dispatches it with full instructions, on tracked global delivery.

Safety

Reported effects with VIP or aviptadil in clinical research include flushing, headache, nausea, diarrhoea, reduced blood pressure and changes in heart rate. Their frequency and severity may differ between products and clinical settings. Allergic reactions are possible, and long-term safety for wellness use is uncertain.

Our clinicians assess potential interactions and determine whether monitoring and follow-up are appropriate. Any new or worsening symptoms should be reported promptly; fainting, chest pain, breathing difficulty or swelling of the face or throat require urgent medical attention.

Questions

Is VIP naturally occurring?

Yes. VIP is produced naturally in the body and participates in normal cell signalling. Being naturally occurring does not mean that additional VIP is safe or beneficial.

Is VIP 5mg a licensed medicine?

This VIP pen is not a UK-authorised medicine for wellness or longevity. Supply through our licensed facility does not confer a product marketing authorisation. Our clinicians explain the applicable licensing status and its implications before any prescribing decision.

What does the supplied presentation include?

The presentation is a branded VIP 5mg pre-filled pen with a case. Supply is subject to an online consultation, a prescription and clinician approval.

Are wellness or longevity benefits established?

No. Current evidence does not establish wellness or longevity benefits for this VIP pen. Biological plausibility and findings from other settings are not substitutes for robust, product-relevant clinical evidence.

This information is educational and not a substitute for advice from your clinician. Prescription treatments are only supplied after a clinical consultation.

Often considered together

Many clients start with a blood test so their clinician has a full picture.

ARA-290 (Cibinetide) 10mgARA-290 (Cibinetide) 10mg

ARA-290 (Cibinetide) 10mg

ARA-290 (Cibinetide) 10mg is an investigational erythropoietin-derived peptide, considered only after online consultation and clinician approval.

10mg pen
BPC-157 + TB-500 Blend 10mgBPC-157 + TB-500 Blend 10mg

BPC-157 + TB-500 Blend 10mg

A two-component blend without controlled human evidence that the combination improves recovery or offers added benefit.

10mg total; component quantities require verification
BPC-157 5mgBPC-157 5mg

BPC-157 5mg

A synthetic 15-amino-acid peptide with predominantly rodent evidence and no established clinical benefit for injury recovery.

5mg